Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tongyang Xuanbi
- Development stage
- Unknown
- Lead developer
- Yueyang Hospital of Integrated Traditional Chinese and Western Medicine
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Tongyang Xuanbi is a Traditional Chinese Medicine (TCM) formula developed by the Yueyang Integrated Traditional Chinese and Western Medicine Hospital, which is affiliated with the Shanghai University of Traditional Chinese Medicine. The formula is specifically designed to treat gastroesophageal reflux disease (GERD) and associated chest pain, often categorized in TCM as "Chest Bi" (obstruction of Qi and Yang in the chest). Its therapeutic approach focuses on "unblocking Yang" (Tongyang) and "relieving Bi-syndrome" (Xuanbi) to alleviate symptoms such as retrosternal pain, acid regurgitation, and heartburn. Clinical research conducted at the Yueyang Hospital suggests that the formula may modulate gastrointestinal motility and improve the integrity of the esophageal mucosal barrier, providing a multi-target intervention for patients with refractory GERD or non-cardiac chest pain.
- Other names
- Tongyang Xuanbi decoctionTongyang Xuanbi formulaTongyang Xuanbi granuleTongyang Xuanbi Tang
Beyond the preview
Go deeper on Tongyang Xuanbi.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Tongyang Xuanbi.